EUVIMEDEUVIMED entdecken
Crossref

Ribosomal S6 kinase 4 (RSK4) tumor suppressor gene promoter methylation status in ovarian cancer

Fabian Arechavaleta-Velasco, Pablo Dominguez-Lopez, Ernesto Acosta-Jimenez, Laura Diaz-Cueto

Molecular Biology Reports · 2023

DOI: 10.1007/s11033-023-08609-9 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Biology Reports, 2023. Verfasst von Fabian Arechavaleta-Velasco und 3 weiteren Autor:innen. Beteiligte Einrichtung: Unidad de Investigación Médica en Medicina Reproductiva, UMAE Hospital de Gineco-Obstetricia No. 4 "Luis Castelazo Ayala", Instituto Mexicano del Seg…. Hauptthemen laut MEDLINE: Ovarian Neoplasms, Ribosomal Protein S6 Kinases, 90-kDa. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 26 Literaturangaben. Gefördert von: Instituto Mexicano del Seguro Social.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Previously, we reported lower RSK4 mRNA and protein levels in malignant ovarian tumors compared to normal and benign ovarian tissues. Also, we observed a significant inverse correlation between the advanced ovarian cancer stages and RSK4 mRNA levels. We did not investigate the mechanisms involved in RSK4-reduced expression in ovarian cancer. Thus, this study investigates whether RSK4 promoter methylation in ovarian cancer tissues is responsible for its low expression. Additionally, the reactivation of RSK4 expression and its effect was studied in ovarian cancer cell lines. METHODS AND RESULTS: RSK4 promoter methylation percentage in malignant and benign ovarian tumors and normal ovary tissues was determined by combined bisulfite restriction analysis. The reactivation of RSK4 expression by decitabine treatment was studied in OVCAR3, SKOV3, TOV-112D, and TOV-21G cells by Western blotting. Cell proliferation was determined by XTT. A significantly high methylation percentage of the RSK4 promoter was observed among malignant and benign ovarian tumors but not in normal ovarian tissue. RSK4 promoter methylation was not associated with age, histological subtype, or stages of ovarian cancer. RSK4 promoter methylation correlates weakly but not significantly with RSK4 protein expression. No correlation was shown between RSK4 methylation and RSK4 mRNA expression. Decitabine induces RSK4 reactivation in all cell lines. However, cell proliferation was reduced only in TOV-112D cells. CONCLUSION: These data indicate that although RSK4 promoter methylation is increased in malignant ovarian tumors, this mechanism is unlikely to regulate its expression in ovarian cancer. RSK4 reactivation reduced cell proliferation only in the endometroid histological subtype.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Ovarian NeoplasmsRibosomal Protein S6 Kinases, 90-kDaFemaleHumansApoptosisCell Line, TumorDecitabineDNA MethylationGene Expression Regulation, NeoplasticGenes, Tumor SuppressorRNA, MessengerPromoter Regions, Genetic

Stichwörter der Autor:innen

MethylationOvarian cancerRibosomal S6 kinase 4 (RSK4)

Substanzen

DecitabineRNA, MessengerRPS6KA6 protein, humanRibosomal Protein S6 Kinases, 90-kDa

Autor:innen und Institutionen

  • Unidad de Investigación Médica en Medicina Reproductiva, UMAE Hospital de Gineco-Obstetricia No. 4 "Luis Castelazo Ayala", Instituto Mexicano del Seguro Social, Av. Rio Magdalena No. 289, Sexto piso. Tizapán, San Angel,…
  • Hospital Angeles del Pedregal, Mexico City, Mexico.

Förderung

  • Instituto Mexicano del Seguro Social

Zitieren

APA

Arechavaleta-Velasco, F., Dominguez-Lopez, P., Acosta-Jimenez, E., & Diaz-Cueto, L. (2023). Ribosomal S6 kinase 4 (RSK4) tumor suppressor gene promoter methylation status in ovarian cancer. Molecular Biology Reports. https://doi.org/10.1007/s11033-023-08609-9

Vancouver

Arechavaleta-Velasco F, Dominguez-Lopez P, Acosta-Jimenez E, Diaz-Cueto L. Ribosomal S6 kinase 4 (RSK4) tumor suppressor gene promoter methylation status in ovarian cancer. Molecular Biology Reports. 2023. doi:10.1007/s11033-023-08609-9

BibTeX
@article{ArechavaletaVelasco2023,
  author = {Arechavaleta-Velasco, Fabian and Dominguez-Lopez, Pablo and Acosta-Jimenez, Ernesto and Diaz-Cueto, Laura},
  title = {Ribosomal S6 kinase 4 (RSK4) tumor suppressor gene promoter methylation status in ovarian cancer},
  journal = {Molecular Biology Reports},
  year = {2023},
  doi = {10.1007/s11033-023-08609-9}
}
Kostenlos starten →